Minor consumer holidays don’t just appear out of nowhere. There’s a method to the madness—and it’s juicier than you’d think.

Enhance habitats for bats in your garden or community. Discover tips and guidance to create a welcoming environment for these ...

UBS upgraded Roche (RHHBY) to Buy from Neutral with a price target of CHF 338, up from CHF 300. The company offers sustainable growth with ...

Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...

Ali Roche has been appointed director of LUX. Roche is currently chief curator at Nottingham Contemporary and was previously ...

Three athletes from Charlotte’s Corvian Community won NCHSAA 1A/2A indoor track championships Friday in Winston-Salem. ▪ ...

In the face of decreasing access to buyers, sales organizations often increase the volume of their sales outreach, hoping ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

Rubin 3-4 0-2 6, Dawson 6-14 6-6 24, Edwards 7-18 0-0 21, Houinsou 1-2 0-1 2, Watson 7-14 2-3 19, Quinn 4-5 1-1 10, Nwaokorie 1-5 2-2 5, DeLoach 0-2 0-0 0, Glazkov 0-1 0-0 0. Totals 29-65 11-15 87.

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).